Firm News: Jun. 2015

Taking SGLT2 Inhibitors May Result in Diabetic Ketoacidosis

W&L is now accepting cases of diabetic ketoacidosis that resulted in the hospitalization or death of people who ingested any of the sodium glucose cotransporter-2 (SGLT2) inhibitors. SGLT2 inhibitors are a class of medications indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. This drug…

Injuries to North Shore L.I. Patients from Data Breach Investigated by W&L

Personal records and insurance information on 18,000 North Shore-Long Island Jewish Health System patients were compromised by a data breach that occurred last year in Texas but went undisclosed for many months, and now Weitz & Luxenberg P.C. is considering filing negligence, economic injury and failure-to-warn claims against Dallas-based Global Care Delivery, the law firm…

W&L Exploring Reports of Zimmer ProxiLock Hip Femur Fracture Rates

Prompted by a recent study, Weitz & Luxenberg, P.C. is investigating the ProxiLock Hip Prosthesis stem manufactured by Zimmer Inc. The implant was originally manufactured by Implex Corp., and was given 510(k) approval by at least October, 2002. Zimmer Inc. announced an agreement to acquire Implex in November, 2003. The study, “Increased Risk of Periprosthetic…

W&L Investigating Maquet’s TigerPaw System II Recall Cases

W&L has begun looking into the dangers of using the TigerPaw System II during occlusion of the heart’s left atrial appendage, a procedure sometimes performed in patients with atrial fibrillation to prevent blood clots from collecting and traveling to other parts of the body. The firm has discovered reports regarding the closure device reported in…

W&L Is Told 95% of Eligible Stryker Hip Patients Enrolled in Settlement

Nationally prominent personal injury law firm Weitz & Luxenberg, P.C., today said that 95 percent of registered eligible patients are now enrolled in the Stryker modular hip settlement program. This program has been established to ensure that each injured patient will receive a share of more than $1 billion as compensation for problems encountered with…